Riverstone Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $251K | Buy |
1,353
+3
| +0.2% | +$557 | 0.14% | 52 |
|
|
2025
Q1 | $283K | Buy |
1,350
+2
| +0.1% | +$419 | 0.17% | 41 |
|
|
2024
Q4 | $240K | Buy |
1,348
+3
| +0.2% | +$533 | 0.14% | 45 |
|
|
2024
Q3 | $266K | Buy |
1,345
+2
| +0.1% | +$395 | 0.15% | 38 |
|
|
2024
Q2 | $230K | Buy |
1,343
+3
| +0.2% | +$514 | 0.14% | 40 |
|
|
2024
Q1 | $244K | Buy |
1,340
+3
| +0.2% | +$546 | 0.15% | 38 |
|
|
2023
Q4 | $207K | Buy |
+1,337
| New | +$207K | 0.13% | 47 |
|